The Suitability of Sniff Dog as a Tool in Screening Tumors

Sponsor
Chang-Qing Gao (Other)
Overall Status
Recruiting
CT.gov ID
NCT02049645
Collaborator
(none)
4,000
1
109.9
36.4

Study Details

Study Description

Brief Summary

Previous studies have demonstrated that sniff dogs can identify cancer patients from healthy subjects through sniffing exhaled breath air or blood or serum or urine or feces. It is hypothesized that sniff dogs may be used as a tool in screening cancer patients in health examination. Trained dogs will sniff serum from participants who are attending the annual health examination to identify potential or high risk subjects, and the results will be compared with the outcome of the traditional health examination, and the high risk subjects will be followed periodically for at least five years.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    4000 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    The Suitability of Sniff Dog as a Tool in Screening Tumors-- a Prospective Observational Study
    Study Start Date :
    Jan 1, 2014
    Anticipated Primary Completion Date :
    Nov 1, 2021
    Anticipated Study Completion Date :
    Mar 1, 2023

    Arms and Interventions

    Arm Intervention/Treatment
    faculty staff and their adult family members

    faculties and their adult family members of the Third Xiang-Ya Hospital

    Outcome Measures

    Primary Outcome Measures

    1. Sensitivity and specificity in screening cancer patients [up to 5 years]

      The results that obtained from the dogs will be compared with these of the pathological examinations. Sensitivity = the No. of patients identified by the dogs as cancers / the No. of patients suffering from cancer confirmed by pathological examination. Specificity = No. of subjects signaled by the dog as non-cancers / No. of subjects confirmed by pathological examination or the currently used methods as non-cancer subjects or at the end of the study, 5 years later still without cancer.

    Secondary Outcome Measures

    1. Behavior patterns of sniff dogs to different diseases [up to 5 years]

      The behavior (lying before the tank for positive, neglecting the tanks) of the dog will be recorded and compared with the results of the pathological examination.

    Other Outcome Measures

    1. The substances used by the sniff dogs to identifying tumors [up to 5 years]

      GCMS etc will be used to compare the volatile compounds between the sera from cancers patients and the from normal subjects, the suspected VOCs will be tested by the dog for conformation.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    20 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • old than 20 years

    • currently without cancer diagnosed with pathological examination

    • allow the study team to examine his/her case history and incoming record

    Exclusion Criteria:
    • cancer patients with pathological diagnosis

    • who does not allow the study team to examine his/her case history and incoming record

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 The Third Xiang-Ya Hospital Changsha Hunan China 410013

    Sponsors and Collaborators

    • Chang-Qing Gao

    Investigators

    • Principal Investigator: Chang-Qing Gao, MD PhD, Central South University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Chang-Qing Gao, MD PhD, Central South University
    ClinicalTrials.gov Identifier:
    NCT02049645
    Other Study ID Numbers:
    • Xiang-Ya 0001
    First Posted:
    Jan 30, 2014
    Last Update Posted:
    Oct 29, 2020
    Last Verified:
    Oct 1, 2020
    Keywords provided by Chang-Qing Gao, MD PhD, Central South University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Oct 29, 2020